Home - Products - Others - Other Targets - Delphinidin-3,5-O-diglucoside chloride

Delphinidin-3,5-O-diglucoside chloride

CAS No. 17670-06-3

Delphinidin-3,5-O-diglucoside chloride( —— )

Catalog No. M31221 CAS No. 17670-06-3

Delphinidin-3,5-O-diglucoside chloride has antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 639 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Delphinidin-3,5-O-diglucoside chloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Delphinidin-3,5-O-diglucoside chloride has antioxidant activity.
  • Description
    Delphinidin-3,5-O-diglucoside chloride has antioxidant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17670-06-3
  • Formula Weight
    663
  • Molecular Formula
    C27H31O17Cl
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Osteocalcin (45-49) ...

    Bone Gla Protein (45-49) is the 45-49 fragment of gamma-carboxyglutamic acid (GLA)-containing protein from bone (BGP, osteocalcin), which has chemotactic activity in vitro for a number of cells which are found adjacent to endosteal bone surfaces in vivo.

  • Hydroxy-ε-sanshool

    Hydroxy-Epsilon-Sanshool is an alkylamide isolated from Zanthoxylum bungeanum. Hydroxy-Epsilon-Sanshool produces key tingling and numbing chemosensates, and its content is important in determinant the pungency intensity of Zanthoxylum bungeanum.

  • TNG908

    TNG908 is an orally active and selective MTAP-co-PRMT5 inhibitor that crosses the blood-brain barrier and kills MTAP-deficient cancers.